Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells.
Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells.
复制标题
永生化 CRL2504 细胞中染色体间隔 1q21.1 的 SV40 整合位点的作用。
DOI:
10.1158/0008-5472.can-09-1003
复制
发表时间:
2009
期刊:
影响因子:
11.2
通讯作者:
Athwal,RaghbirS
中科院分区:
文献类型:
--
作者:
Liu,Jinglan;Kaur,Gurpreet;Zhawar,VikramjitK;Zimonjic,DrazenB;Popescu,NicholasC;Kandpal,RajP;Athwal,RaghbirS
We have applied a functional gene transfer strategy to show the importance of viral integration site in cellular immortalization. The large tumor antigen of SV40 is capable of extending the cellular life span by sequestering tumor suppressor proteins pRB and p53 in virus-transformed human cells. Although SV40 large T antigen is essential, it is not sufficient for cellular immortalization, suggesting that additional alterations in cellular genes are required to attain infinite proliferation. We show here that the disruption of human chromosomal interval at 1q21.1 by SV40 integration can be an essential step for cellular immortalization. The transfer of a 150-kb bacterial artificial chromosome (BAC) clone, RP364B14, corresponding to viral integration site in CRL2504 cells, reverted their immortal phenotype. Interestingly, the BAC transfer clones of CRL2504 cells displayed characteristics of either senescence as shown by β-galactosidase activity or apoptosis as revealed by positive staining with M30 CytoDEATH antibody. The SV40 integration at 1q21.1, in the vicinity of epidermal differentiation complex (EDC) genes, resulted in the down-regulation of thefilaggrin(FLG) gene that is part of theEDC.FLGgene expression was increased in BAC transfer senescent and apoptotic clones. Our results suggest that the disruption of native genomic sequence by SV40 may alter expression of genes involved in senescence and apoptosis by modulating chromatin structure. These studies imply that identification of genes located in the vicinity of viral integration sites in human cancers may be helpful in developing new diagnostic and therapeutic strategies. [Cancer Res 2009;69(19):7819–25]